Pneumoconiosis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 6: | Line 6: | ||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
Future therapies are being experimented on including inhibiting cytokines and the use of antioxidants. Investigational therapy also includes administration of bone marrow-derived mononuclear cells. <ref name="pmid15699791">{{cite journal| author=Rimal B, Greenberg AK, Rom WN| title=Basic pathogenetic mechanisms in silicosis: current understanding. | journal=Curr Opin Pulm Med | year= 2005 | volume= 11 | issue= 2 | pages= 169-73 | pmid=15699791 | doi=10.1097/01.mcp.0000152998.11335.24 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15699791 }} </ref> <ref name="pmid20693250">{{cite journal| author=Maron-Gutierrez T, Castiglione RC, Xisto DG, Oliveira MG, Cruz FF, Peçanha R | display-authors=etal| title=Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis. | journal=Eur Respir J | year= 2011 | volume= 37 | issue= 5 | pages= 1217-25 | pmid=20693250 | doi=10.1183/09031936.00205009 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20693250 }} </ref> <ref name="pmid25723826">{{cite journal| author=Cavalli G, Fallanca F, Dinarello CA, Dagna L| title=Treating pulmonary silicosis by blocking interleukin 1. | journal=Am J Respir Crit Care Med | year= 2015 | volume= 191 | issue= 5 | pages= 596-8 | pmid=25723826 | doi=10.1164/rccm.201412-2150LE | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25723826 }} </ref> | |||
==References== | ==References== | ||
Revision as of 21:15, 28 April 2021
|
Pneumoconiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pneumoconiosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Pneumoconiosis future or investigational therapies |
|
Pneumoconiosis future or investigational therapies in the news |
|
Risk calculators and risk factors for Pneumoconiosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
Future or Investigational Therapies
Future therapies are being experimented on including inhibiting cytokines and the use of antioxidants. Investigational therapy also includes administration of bone marrow-derived mononuclear cells. [1] [2] [3]
References
- ↑ Rimal B, Greenberg AK, Rom WN (2005). "Basic pathogenetic mechanisms in silicosis: current understanding". Curr Opin Pulm Med. 11 (2): 169–73. doi:10.1097/01.mcp.0000152998.11335.24. PMID 15699791.
- ↑ Maron-Gutierrez T, Castiglione RC, Xisto DG, Oliveira MG, Cruz FF, Peçanha R; et al. (2011). "Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis". Eur Respir J. 37 (5): 1217–25. doi:10.1183/09031936.00205009. PMID 20693250.
- ↑ Cavalli G, Fallanca F, Dinarello CA, Dagna L (2015). "Treating pulmonary silicosis by blocking interleukin 1". Am J Respir Crit Care Med. 191 (5): 596–8. doi:10.1164/rccm.201412-2150LE. PMID 25723826.